Literature DB >> 19782443

Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis.

Barkha P Patel1, Mazen J Hamadeh.   

Abstract

BACKGROUND & AIMS: Disease pathogenesis in amyotrophic lateral sclerosis (ALS) involves a number of interconnected mechanisms all resulting in the rapid deterioration of motor neurons. The main mechanisms include enhanced free radical production, protein misfolding, aberrant protein aggregation, excitotoxicity, mitochondrial dysfunction, neuroinflammation and apoptosis. The aim of this review is to assess the efficacy of using nutrition- and exercise-related interventions to improve disease outcomes in ALS.
METHODS: Studies involving nutrition or exercise in human and animal models of ALS were reviewed.
RESULTS: Treatments conducted in animal models of ALS have not consistently translated into beneficial results in clinical trials due to poor design, lack of power and short study duration, as well as differences in the genetic backgrounds, treatment dosages and disease pathology between animals and humans. However, vitamin E, folic acid, alpha lipoic acid, lyophilized red wine, coenzyme Q10, epigallocatechin gallate, Ginkgo biloba, melatonin, Cu chelators, and regular low and moderate intensity exercise, as well as treatments with catalase and l-carnitine, hold promise to mitigating the effects of ALS, whereas caloric restriction, malnutrition and high-intensity exercise are contraindicated in this disease model.
CONCLUSIONS: Improved nutritional status is of utmost importance in mitigating the detrimental effects of ALS.

Entities:  

Mesh:

Year:  2009        PMID: 19782443     DOI: 10.1016/j.clnu.2009.06.002

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  14 in total

1.  Dietary vitamin D3 supplementation at 10× the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2012-05-17       Impact factor: 5.243

2.  Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.

Authors:  Giuliana Castello Coatti; Miriam Frangini; Marcos C Valadares; Juliana Plat Gomes; Natalia O Lima; Natale Cavaçana; Amanda F Assoni; Mayra V Pelatti; Alexander Birbrair; Antonio Carlos Pedroso de Lima; Julio M Singer; Francisco Marcelo M Rocha; Giovani Loiola Da Silva; Mario Sergio Mantovani; Lucia Inês Macedo-Souza; Merari F R Ferrari; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

3.  Home-Based Music Therapy to Support Bulbar and Respiratory Functions of Persons with Early and Mid-Stage Amyotrophic Lateral Sclerosis-Protocol and Results from a Feasibility Study.

Authors:  Alisa T Apreleva Kolomeytseva; Lev Brylev; Marziye Eshghi; Zhanna Bottaeva; Jufen Zhang; Jörg C Fachner; Alexander J Street
Journal:  Brain Sci       Date:  2022-04-13

Review 4.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

Review 5.  Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2013-03-19       Impact factor: 5.614

6.  Shifting Tides Toward a Proactive Patient-Centered Approach in Dysphagia Management of Neurodegenerative Disease.

Authors:  Nicole M Rogus-Pulia; Emily K Plowman
Journal:  Am J Speech Lang Pathol       Date:  2020-07-10       Impact factor: 2.408

7.  Unlike physical exercise, modified environment increases the lifespan of SOD1G93A mice however both conditions induce cellular changes.

Authors:  Yannick N Gerber; Jean-Charles Sabourin; Jean-Philippe Hugnot; Florence E Perrin
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

8.  Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Jesse A Solomon; Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

9.  Dietary Vitamin D3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Elnaz Moghimi; Jesse A Solomon; Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

10.  Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females.

Authors:  Alexandro Gianforcaro; Jesse A Solomon; Mazen J Hamadeh
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.